Position in BIIB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$20,493,291
+$491,988 QoQ
Shares Held
94,850
-13.1% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
1.93%
of 13F equity value
Holder Rank
#118
of 1,036 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $173,015,372 across 8 Drug Manufacturers - General names. BIIB ranks #6 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
151,500 | $28,727,430 | |
| 2 | MRK |
Merck & Co., Inc.
|
213,500 | $27,434,750 | |
| 3 | LLY |
ELI LILLY & Co
|
22,315 | $26,765,282 | |
| 4 | ABBV |
AbbVie Inc.
|
96,775 | $24,352,461 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
178,250 | $22,520,105 | |
| 6 | BIIB |
Biogen Inc.
This page
|
94,850 | $20,493,291 | |
| 7 | JNJ |
Johnson & Johnson
|
72,500 | $18,412,825 | |
| 8 | AMGN |
Amgen Inc
|
11,900 | $4,309,228 |
All Filings in BIIB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,493,291 | 94,850 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $20,001,303 | 109,100 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,252,676 | 92,350 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,704,400 | 55,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,507,080 | 12,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,773,580 | 49,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $18,916,204 | 123,700 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $13,006,664 | 67,100 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $19,658,336 | 84,800 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $12,247,784 | 56,800 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,182,553 | 58,672 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $14,521,065 | 56,500 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $18,372,825 | 64,500 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $13,206,425 | 47,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,307,600 | 30,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,752,794 | 32,782 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $3,159,000 | 15,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $27,590,800 | 115,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $42,448,500 | 150,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $31,164,300 | 90,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,455,125 | 19,500 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $9,794,400 | 40,000 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $9,361,440 | 33,000 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $4,548,350 | 17,000 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $7,909,500 | 25,000 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||